why choose us

First received: January 25, 2023

Clinical Trial: Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amyloidosis

Study Type: INTERVENTIONAL


Official Title: Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Brief Summary: This is a single center prospective study evaluating 124I-evuzumitide in patients with systemic amyloidosis.The purpose of this study is to 1)identify and characterize the distribution and uptake of 124I-evuzumitide in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and 2) Correlate the uptake with the structure and function of different organs, including the heart.To achieve these goals, eligible patients will undergo primarily hybrid positron emission tomography and magnetic resonance imaging…

Read more